insights_auto
Why is NEO up 2.12%?
Dive Deeperchevron_right
NEO:NASDAQ
NeoGenomics, Inc.
$16.84
arrow_upward
+2.12%(+0.35) 1D
$16.84
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
$16.85
High
$16.93
Low
$16.12
Mkt. cap
2.18B
Avg. vol.
2.12M
Volume
1.31M
52-wk high
$20.15
52-wk low
$7.06
EPS
-$0.25
Beta
1.87
Shares outstanding
129.39M
No. of employees
2K
Open
$16.85
High
$16.93
Low
$16.12
Mkt. cap
2.18B
Avg. vol.
2.12M
Volume
1.31M
52-wk high
$20.15
52-wk low
$7.06
EPS
-$0.25
Beta
1.87
Shares outstanding
129.39M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
20 hours ago
Did Narrower Quarterly Loss Just Shift NeoGenomics Stock Investment Narrative?
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2.5K
Founded2002
HeadquartersFort Myers, Florida, United States
SectorHealth Care
IndustryHealth care provider
Websiteneogenomics.com